Global In Vitro Diagnostics (IVD) Quality Control Market, By Product and Service (Quality Control Products, Data Management Solutions, Quality Assurance Services), Application (Immunochemistry/Immunoassay, Clinical Chemistry, Hematology, Molecular Diagnostics, Coagulation and Hemostasis, Microbiology, Others), Manufacturer Type (Third-Party Control Manufacturers, Original Equipment Manufacturers), End- Users (Hospitals, Clinical Laboratories, Academic and Research Institutes, Other End Users), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029.
Market Analysis and Insights Global In Vitro Diagnostics (IVD) Quality Control Market
The in vitro diagnostics (IVD) quality control market is expected to witness market growth at a rate of 4.3% in the forecast period of 2022 to 2029. Data Bridge Market Research report on in vitro diagnostics (IVD) quality control market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the healthcare sector globally is escalating the growth of in vitro diagnostics (IVD) quality control market.
In-vitro diagnostics (IVDs) refer to the type of medical devices and accessories that are specially designed for conducting in-vitro testing on body samples such as blood, tissues, and urine. These medical devices are widely utilized for the diagnosis and treatment of various medical conditions.
The increase in the number of accredited clinical laboratories across the globe acts as one of the major factors driving the growth of in vitro diagnostics (IVD) quality control market. The increase in the geriatric population and subsequent growth in the prevalence of chronic and infectious diseases accelerate the market growth. The increase in adoption of POC instruments in developed regions and rise in number of accredited clinical laboratories further influence the market. Additionally, advancements in healthcare infrastructure, high disposable income, surge in healthcare expenditure and rise in healthcare expenditure positively affect the in vitro diagnostics (IVD) quality control market. Furthermore, rise in demand for multi-analyte controls extend profitable opportunity to the market players in the forecast period of 2022 to 2029.
On the other hand, additional costs and budget constraints in hospitals and laboratories, and unfavorable reimbursement scenario for IVD tests are expected to obstruct the market growth. Lack of regulations for clinical laboratory accreditation and stringent product approval process are projected to challenge the in vitro diagnostics (IVD) quality control market in the forecast period of 2022-2029.
This in vitro diagnostics (IVD) quality control market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on in vitro diagnostics (IVD) quality control market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global In Vitro Diagnostics (IVD) Quality Control Market Scope and Market Size
The in vitro diagnostics (IVD) quality control market is segmented on the basis of product and services, application, manufacturer type, and end- users. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product, the in vitro diagnostics (IVD) quality control market is segmented into quality control products, data management solutions and quality assurance services. Quality control products are further segmented into serum/plasma-based controls, whole blood-based controls, urine-based controls and other source-based IVD quality controls.
- Application segment of the in vitro diagnostics (IVD) quality control market is segmented into immunochemistry/immunoassay, clinical chemistry, hematology, molecular diagnostics, coagulation and hemostasis, microbiology and others.
- Based on manufacturer type, in vitro diagnostics (IVD) quality control market is divided into third-party control manufacturers and original equipment manufacturers. Third- party control manufacturer segment is divided into independent clinics and instrument- specific control.
- End user segment of the in vitro diagnostics (IVD) quality control market is divided into hospitals, clinical laboratories, academic and research institutes, and other end user.
In Vitro Diagnostics (IVD) Quality Control Market Country Level Analysis
The in vitro diagnostics (IVD) quality control market is analyzed and market size insights and trends are provided by country, product and services, application, manufacturer type, and end- users as referenced above.
The countries covered in the in vitro diagnostics (IVD) quality control market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the in vitro diagnostics (IVD) quality control market because of the presence of well-established distribution channels within the region. Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the high healthcare costs and increasing patient queues for treatment in the region.
The country section of the in vitro diagnostics (IVD) quality control market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The in vitro diagnostics (IVD) quality control market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for in vitro diagnostics (IVD) quality control market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the in vitro diagnostics (IVD) quality control market. The data is available for historic period 2010-2020.
Competitive Landscape and In Vitro Diagnostics (IVD) Quality Control Market Share Analysis
The in vitro diagnostics (IVD) quality control market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to in vitro diagnostics (IVD) quality control market.
Some of the major players operating in the in vitro diagnostics (IVD) quality control market report are Bio-Rad Laboratories, Inc, Thermo Fisher Scientific Inc., SeraCare Life Sciences Inc., Randox Laboratories Ltd., Siemens Healthcare Private Limited., Technopath Clinical Diagnostics., Sun Diagnostics, LLC., Ortho Clinical Diagnostics, BD., Sysmex Corporation, and bioMérieux, Inc., among others.
SKU-